Prescribing practices for presumptive TB among private general practitioners in South Africa: a cross-sectional, standardized patient study
OUTPUT TYPE: Journal Article
PUBLICATION YEAR: 2022
TITLE AUTHOR(S): A.Salomon, J.Boffa, S.Moyo, J.Chikovore, G.Sulis, B.Daniels, A.Kwan, T.Mkhombo, S.Wu, M.Pai, A.Daftary
KEYWORDS: HIV/AIDS, PRIVATE HEALTH SERVICES, TUBERCULOSIS
DEPARTMENT: Public Health, Societies and Belonging (HSC)
Print: HSRC Library: shelf number 9812294
HANDLE: 20.500.11910/19282
URI: http://hdl.handle.net/20.500.11910/19282
If you would like to obtain a copy of this Research Output, please contact Hanlie Baudin at researchoutputs@hsrc.ac.za.
Abstract
Medicine prescribing practices are integral to quality of care for leading infectious diseases such as tuberculosis (TB). We describe prescribing practices in South Africas private health sector, where an estimated third of people with TB symptoms first seek care. Sixteen standardised patients (SPs) presented one of three cases during unannounced visits to private general practitioners (GPs) in Durban and Cape Town: TB symptoms, HIV-positive; TB symptoms, a positive molecular test for TB, HIV-negative; and TB symptoms, history of incomplete TB treatment, HIV-positive. Prescribing practices were recorded in standardised exit interviews and analysed based on their potential to contribute to negative outcomes, including increased healthcare expenditures, antibiotic overuse or misuse, and TB diagnostic delay. Factors associated with antibiotic use were assessed using Poisson regression with a robust variance estimator. Between August 2018 and July 2019, 511 SP visits were completed with 212 GPs. In 88.5% (95% CI 85.2% to 91.1%) of visits, at least one medicine (median 3) was dispensed or prescribed and most (93%) were directly dispensed. Antibiotics, which can contribute to TB diagnostic delay, were the most common medicine (76.5%, 95%CI 71.7% to 80.7% of all visits). A majority (86.1%, 95%CI 82.9% to 88.5%) belonged to the WHO Access group; fluoroquinolones made up 8.8% (95% CI 6.3% to 12.3%). Factors associated with antibiotic use included if the SP was asked to follow-up if symptoms persisted (RR 1.14, 95%CI 1.04 to 1.25) and if the SP presented as HIV-positive (RR 1.11, 95%CI 1.01 to 1.23). An injection was offered in 31.9% (95% CI 27.0% to 37.2%) of visits; 92% were unexplained. Most (61.8%, 95%CI 60.2% to 63.3%) medicines were not listed on the South African Primary Healthcare Essential Medicines List. Prescribing practices among private GPs for persons presenting with TB-like symptoms in South Africa raise concern about inappropriate antimicrobial use, private healthcare costs and TB diagnostic delay.-
Related Research Outputs:
- Quality of care for tuberculosis and HIV in the private health sector: a cross-sectional, standardised patient study in South Africa
- Completion of the tuberculosis care cascade in a community-based HIV linkage linkage-to-care study in South Africa and Uganda
- Letter to the editor: Why we need to evaluate the quality of tuberculosis care in South Africa's private health sector
- Society's successful men: what this means for TB intervention design
- Quality of TB care in South Africa's private sector
- The additional financial burden of care-seeking for TB symptoms in SA's private sector
- Factors influencing patients' willingness to return to private providers for TB diagnostic care: insight from a standardised patient study in South Africa
- Missing men with tuberculosis: the need to address structural influences and implement targeted and multidimensional interventions
- Predictors of suboptimal adherence to isoniazid preventive therapy among adolescents and children living with HIV
- Report on the joint tuberculosis and HIV pilot survey in KwaZulu-Natal, South Africa 2019
- Feasibility of implementing the advanced HIV disease care package as part of community-based HIV/TB activities: a mixed-methods study protocol
- Access to gender-affirming HIV, STI and TB services for transgender women in South Africa
- Task oriented nursing in a tuberculosis control programme in South Africa: where does it come from and what keeps it going?
- Perceptions of tuberculosis: attributions of cause, suggested means of risk reduction, and preferred treatment in the Limpopo province, South Africa
- HIV/AIDS, tuberculosis and parasites
- Delivery of the directly observed therapy (DOT) for tuberculosis patients in the Limpopo province, South Africa: a qualitative study
- HIV/AIDS/STI/TB knowledge, beliefs and practices of traditional healers in KwaZulu-Natal, South Africa
- A controlled study of an HIV/AIDS/STI/TB intervention with traditional healers in KwaZulu-Natal, South Africa
- HIV/AIDS/STI/TB knowledge, attitudes and practices among lay health workers and nurses in KwaZulu-Natal, South Africa
- Bayesian approach in estimating risk determinants of infectious diseases